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Introduction
E-cadherin functions as a Ca
2+-dependent adhesion molecule 
through its extracellular region (Takeichi, 1995); its cytoplas-
mic portion is a cortical organizer that binds catenins and vari-
ous cytoskeletal and signaling molecules (Braga, 2002; Perez- 
Moreno et al., 2003; Mège et al., 2006). Overall, E-cadherin is 
a system developer that integrates cell–cell adhesion and intra-
cellular events to support the complex functional organization 
of epithelial cell sheets, which are essential in multicellular   
organisms (Perez-Moreno et al., 2003; Lecuit, 2005; Brembeck 
et al., 2006). Accumulating evidence indicates that the EMT 
(epithelial–mesenchymal transition)-dependent or -independent 
regulation of E-cadherin expression is critical for essential 
biological events, including development, differentiation, and 
regeneration, and for carcinogenesis (Gumbiner, 2005; Halbleib 
and Nelson, 2006; Jeanes et al., 2008). However, in contrast   
to E-cadherin’s EMT-dependent transcriptional regulation, the 
EMT-independent mechanism is not well understood, although 
it generally occurs when epithelial sheets are modulated with-
out their cell–cell adhesions being disrupted.
E-cadherin and other types of classical cadherins are highly 
enriched in the adherens junctions (AJs) and integrated into vari-
ous signaling cascades, which allows epithelial cell sheets to 
change their configurations as required for various biological 
events (Wheelock et al., 2008; Nishimura and Takeichi, 2009). The 
mixed expression of classical cadherins changes cell–cell inter-
actions both by homophilic interactions through the cadherins’ 
T
he spatiotemporal regulation of E-cadherin expres-
sion  is  important  during  body  plan  development 
and  carcinogenesis.  We  found  that  Tara  (Trio- 
associated repeat on actin) is enriched in cadherin-based 
adherens junctions (AJs), and its knockdown in MDCK 
cells (Tara-KD cells) significantly decreases the expression 
of E-cadherin. Tara-KD activates Rac1 through the Trio 
RhoGEF, which binds to E-cadherin and subsequently in-
creases the phosphorylation of p38 and Tbx3, a tran-
scriptional E-cadherin repressor. Accordingly, the decrease 
in  E-cadherin  expression  is  abrogated  by  ITX3  and 
SB203580  (specific  inhibitors  of  Trio  RhoGEF  and 
p38MAPK,  respectively),  and  by  dephosphomimetic   
Tbx3. Despite the decreased E-cadherin expression, the 
Tara-KD cells do not undergo an epithelial–mesenchymal 
transition and remain as an epithelial cell sheet, presumably 
due  to  the  concomitant  up-regulation  of  cadherin-6. 
Tara-KD reduces the actin-belt density in the circumferen-
tial ring, and the cells form flattened cysts, suggesting that 
Tara functions to modulate epithelial cell sheet formation 
and integrity by up-regulating E-cadherin transcription.
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We also found that Tara-KD reduced the packing density 
of actin in the AJ-associated CR by decreasing the level of   
E-cadherin expression and concomitantly increasing the protein 
level of cadherin-6. We propose that Tara is a critical regulator 
of E-cadherin expression and that Tara modulates the properties 
of the cadherin-based CR and of epithelial cell sheets through 
its regulation.
Results
Tara is an AJ component that affects the 
levels of AJ-associated E-cadherin
In an ongoing proteomic screen of junctional fractions of the 
liver membrane (Tsukita and Tsukita, 1989; Yamazaki et al., 
2008a),  to  find  junctional  components  whose  exogenous   
expression  and/or  knockdown  alter  the  junctional  levels  of   
E-cadherin and/or claudins in cultured epithelial cells, we iden-
tified a molecule that was enriched in junctional fractions and 
whose knockdown decreased E-cadherin; its sequence matched 
that of Tara (Fig. 1 A). We then made stable knockdown cell 
lines of Tara by transfecting MDCK cells with a Tara-specific 
RNAi (Tara-KD cells). To confirm that the effects of Tara-KD 
were  specific,  we  examined  two  independent  constructs  for 
Tara-KD, and obtained the same results. As a control for RNAi-
KD, stable cell lines expressing the empty RNAi expression 
vector  (mock  transfection)  were  used;  cell  lines  expressing 
scrambled constructions of the nucleotides for RNAi-KD were 
also established, and showed the same results as the mock-
transfected cells (Fig. 1 D; Fig. S1 A). Immunoblotting and   
immunofluorescence analyses, using an anti-Tara antibody that 
we produced, showed that Tara colocalized with E-cadherin 
(Fig. 1 B; Fig. S1, B and C).
To compare the intensity of E-cadherin signals precisely 
between mock and Tara-KD cells, equal numbers of control and 
Tara-KD cells were mixed and seeded on a cover glass. In con-
fluent  sheets  of  Tara-KD  cells,  the  E-cadherin  expression   
was lower than in mock-transfected control cell sheets (Fig. 1,   
C and D), and the sheet-like configuration of the cells was main-
tained. In addition, the protein level of cadherin-6, the second 
major cadherin in MDCK cells (Stewart et al., 2000; Capaldo and 
Macara, 2007), was up-regulated by Tara-KD (Fig. 1, C and D), 
suggesting that the down-regulation of Tara at least partly induced 
cadherin switching in these cells. In contrast, the N-cadherin sig-
nal, which was very weak, was unchanged in the Tara-KD cells 
(unpublished data). Neither the protein levels nor the intensities 
of the immunofluorescent signals for cell–cell AJ-associated pro-
teins, such as the -, -, and p120-catenins, occludin, and ZO-1, 
were altered in the Tara-KD cells (Fig. 1, C and E).
Consistent  with  these  findings,  thin-section  electron   
microscopy showed that the ultrastructure of the AJ was un-
affected in the Tara-KD cells (Fig. S1 D). Furthermore, the cell 
proliferation rate, in vitro wound healing, and cell–cell adhe-
sion were all unaffected in these cells (Fig. S2, A–C). Collec-
tively, our results indicate that knocking down Tara decreases 
the expression of E-cadherin, which is accompanied by the 
up-regulation of cadherin-6, without affecting the AJ-based 
epithelial cell sheet organization.
extracellular domains and by altering the properties of the signal 
platform through their cytoplasmic domains. In this respect, the 
regulation of E-cadherin expression and that of other classical 
cadherins is critical for determining the dynamic properties of 
epithelial cell sheets (Perez-Moreno et al., 2003; Nishimura and 
Takeichi, 2009). Although the integrity of epithelial sheets is not 
maintained  during  EMT,  the  EMT-independent  regulation  of   
cadherin expression has recently attracted considerable attention 
because of its role in remodeling epithelial cell sheets without 
destroying the integrity of the cell sheet configuration (Wheelock 
et al., 2008). However, our knowledge about the EMT-independent 
regulation of cadherin expression is still fragmentary.
There is accumulating evidence that the ras-like GTP- 
binding protein (Rho) family members Rac, Rho, and Cdc42 
spatiotemporally regulate the dynamic molecular organization of 
AJ components (Braga, 2002; Etienne-Manneville and Hall, 2002; 
Heasman and Ridley, 2008). A number of guanine nucleotide ex-
change factors (GEFs) are associated with AJs, and are thought to 
specify  the  spatiotemporally  restricted  actions  of  Rho  family 
members (Schmidt and Hall, 2002; Otani et al., 2006). In addi-
tion, GEF-binding proteins may help specify the activities of their 
corresponding GEFs. However, the detailed contribution of Rho-
related proteins to E-cadherin expression has not been reported.
Tbx3 is a member of the T-box family, a family of tran-
scription factors with at least 22 members, each of which is   
involved  in  regulating  particular  developmental  stages  and   
in cancer-related processes (Papaioannou and Silver, 1998;   
Rodriguez et al., 2008). Although the T-box proteins are thought 
to be regulated downstream of WNT and/or BMP signaling 
pathways (Renard et al., 2007), the signaling cascades that reg-
ulate the transcriptional activity or other events downstream of 
the T-box proteins are not fully understood. A recent report 
showed that, in melanoma cells, E-cadherin expression is di-
rectly repressed by Tbx3 and not by EMT-related transcription 
factors, such as Snail and Slug (Rodriguez et al., 2008).
One prominent feature of E-cadherin is its integration into 
the apical belt-like AJ, with which the actin circumferential ring 
(CR) is associated (Yonemura et al., 1995). The AJ/CR complex 
is considered to play a critical role in belt-like arrangement of 
AJ in epithelial cells, which is spatiotemporally regulated in   
order to integrate various extracellular and intracellular compo-
nents (Itoh et al., 1997; Perez-Moreno et al., 2003; Lecuit, 2005; 
Pokutta  and Weis,  2007; Abe  and Takeichi,  2008).  Because   
E-cadherin– and/or other classical cadherin-based catenin/actin 
frameworks are distributed in cell–cell contacts, it is plausible 
that a critical mechanism for integrating these frameworks into 
the AJ/CR system exists at AJs.
Here we show that the Trio-associated repeat on actin 
(Tara) protein is enriched at AJs through its association with 
Trio RhoGEF, a binding partner of E-cadherin. In addition, Tara 
down-regulates the activity of Tbx3, a transcriptional suppres-
sor of E-cadherin, by negatively regulating Trio’s RhoGEF   
activity EMT independently, through a novel signaling cascade 
mediated by Tara/Trio/Rac1/p38/Tbx3. This finding provides a 
conceptually new paradigm for the regulation of E-cadherin, in 
which a specific signaling cascade initiated at the AJ controls 
the activity of a transcriptional suppressor of E-cadherin.321 Tara regulates transcription of E-cadherin • Yano et al.
Figure 1.  Identification of Tara as an AJ component, whose knockdown down-regulates the expression of E-cadherin. (A) Immunoblotting of the liver, bile 
canaliculi (BC), and the cell–cell junctional fraction (JF) with an anti-Tara antibody. Tara was enriched in the BC and JF. (B) Immunofluorescence micrographs 
of MDCK cells. Cells were costained for Tara with E-cadherin or ZO-1 to mark adherens or tight junctions, respectively. Top panels: Tara, green; E-cadherin, 
red. Bottom panels: Tara, green; ZO-1, red. Bar, 10 µm. Tara was colocalized with E-cadherin at cell–cell adherens junctions, at a position basolateral to 
the tight junctions. (C) Immunoblotting of Tara-KD and control MDCK cells (two clones) for cell–cell adhering junctional proteins. Control: mock-transfected 
MDCK cells. KD1 and KD2: Tara-KD MDCK cells (two clones). E-cad, E-cadherin; Cad-6, cadherin-6; -Cat, -catenin; p120, p120-catenin; Vin, vinculin; 
Occ, occludin; Dp, desmoplakin. Loading controls were prepared by probing portions of the same filter by anti–-tubulin and the antibody for the respec-
tive experimental protein, except for Cad-6 and -Cat, which were probed in the presence of the loading control anti–-tub at the same time by mixture of 
antibodies. (D) Immunofluorescence micrographs of co-cultured Tara-KD and control mock-transfected MDCK cells stained for E-cadherin and cadherin-6. 
The E-cadherin signals were decreased in the Tara-KD cells. Note that the cadherin-6 signals were increased by Tara-KD. Tara, green; E-cadherin, red; 
cadherin-6, green (cy5-staining). Bar, 10 µm. (E) Immunofluorescence micrographs of co-cultured Tara-KD and control mock-transfected MDCK cells stained 
for p120- and -catenins. Note that the immunofluorescence levels of the p120- and -catenins at AJs were not changed by Tara-KD.JCB • VOLUME 193 • NUMBER 2 • 2011   322
Figure 2.  Association of Tara with Trio RhoGEF, which binds E-cadherin. (A, a) Coimmunoprecipitations among YFP-E-cadherin, HA-Trio, and HA-Tara. 
After the transient expression (see input) in HEK293 cells of tagged forms of Tara, E-cadherin, and Trio, a reported binding partner of Tara, YFP–E-cadherin 
was detected in the immunoprecipitates of HA-Tara in the presence, but not the absence, of HA-Trio. (b) Linkage between Trio and E-cadherin. HA-Trio was 
pulled down by a GST fusion protein of the cytoplasmic domain of E-cadherin. (c) Immunofluorescence of transiently expressed HA-Trio. The cell–cell AJs lit 
up, as indicated by the Tara costaining pattern. Bar, 5 µm. (B) Schematic drawing of Trio RhoGEF and the Tara deletion constructs. (C) Immunofluorescence 
micrographs of Tara-KD MDCK cells stably transfected with HA-tagged Tara deletion mutants. All the constructs except for the one lacking the mid-domain 
were localized to the AJ and up-regulated the immunofluorescent signals for E-cadherin. HA, green; E-cadherin, red. Bar, 10 µm. (D) Pull-down assay of 
full-length and mid-domain Tara, and full-length Tara lacking the mid-domain, with GST fusion proteins of the Trio RhoGEF RhoG/Rac1-GEF domain (GEF-
D1) or GST (a control). The mid-domain of Tara was essential for Tara’s interaction with the GEF-D1 domain.323 Tara regulates transcription of E-cadherin • Yano et al.
48  h  after  replating  (Fig.  3  C).  Moreover,  cycloheximide,   
but  not  MG132  (a  proteolysis  inhibitor),  suppressed  the 
Tara-KD–induced up-regulation of cadherin-6 (Fig. S3 C). 
These results indicate that E-cadherin is transcriptionally down- 
regulated by the knockdown of Tara, and its down-regulation is 
accompanied by the biosynthesis-dependent post-transcriptional 
increase in cadherin-6 protein. We next asked whether Tara-
KD induced EMT. We found that the mRNA levels of EMT-
related genes like Snail, Slug, Twist, Zeb-1, Zeb-2, N-cadherin, 
-smooth muscle actin, and vimentin were not elevated in   
the Tara-KD cells (unpublished data), and even if Snail was   
exogenously expressed, no changes in expression of Tara  
was  detected.  Collectively,  the  decreased  expression  of   
E-cadherin in the Tara-KD cells was probably not caused by 
a typical EMT.
Because Tara binds the RhoG/Rac1-GEF domain (Trio 
GEF-D1) of Trio RhoGEF (Seipel et al., 2001), we monitored 
the levels of active Rac1 and RhoG in control and Tara-KD 
MDCK cells after EDTA/trypsin treatment and replating. By a 
conventional pull-down assay for the active form of Rac1, we 
found that the level of Rac1 activation was much higher in the 
Tara-KD than the control cells at 24 and 48 h after replating 
(Fig. 3 D), although we could not detect the activated RhoG 
signal in either the control or the Tara-KD cells (Fig. S3 D), 
consistent with a previous report (Backer et al., 2007). In paral-
lel, fluorescence resonance energy transfer (FRET) analyses of 
Rac1 were performed to observe the spatiotemporal activa-
tion patterns in cells, using the Raichu-Rac1 probe (Fig. 3 E; 
Videos 1–6). Activation of Rac1 was observed at the cell–cell 
contacts of the control and Tara-KD cells, 12 and 24 h after re-
plating. However, although active Rac1 was still easily observed 
at cell–cell contacts in the Tara-KD cells 48 h after replating, 
it was scarce in the control cells at this time point (Fig. 3 E; 
Videos 1–6). To confirm that the up-regulation of Rac1 activity 
in the Tara-KD cells was specific, we transfected these cells 
with full-length and deletion constructs of Tara. All of the con-
structs except the one lacking the mid-domain decreased the 
level of active Rac1 (Fig. 4, A and B) and restored the E-cadherin 
levels (Fig. 3 C). We also introduced a dominant-negative   
Rac1 into the Tara-KD cells, and found that it suppressed the 
Tara-KD–induced decrease in E-cadherin expression (Fig. S4 A), 
confirming that Tara’s regulation of Rac1’s activity specifically 
affected the E-cadherin expression.
Tara-KD increases Rac1 activity 
via Trio RhoGEF, which leads to the 
phosphorylation of p38
To examine whether the Rac1 activity was specifically enhanced 
by Trio RhoGEF in Tara-KD cells, we used ITX3, a specific in-
hibitor of the Rac1-GEF activity of Trio RhoGEF (Bouquier   
et al., 2009). ITX3 repressed the Rac1 activity and dose depend-
ently up-regulated the E-cadherin protein level in the Tara-KD 
cells (Fig. 4 D), thereby reversing the effects of Tara-KD (Fig. 4 E). 
The quantification of GTP-Rac1, E-cadherin, and cadherin-6 by 
densitometry (as shown in Fig. S4 B) in three independent ex-
periments showed that 100 µM ITX3 significantly increased the 
E-cadherin expression (by 80%) in the Tara-KD cells compared 
Molecular basis for the association of Tara 
with cell–cell AJs
Given the colocalization of Tara with E-cadherin, we further 
examined their mode of interaction. We transiently expressed 
tagged forms of Tara, E-cadherin, and Trio, which is a reported 
binding partner of Tara, in HEK293 cells and examined the 
binding affinities between them by coprecipitation assay. We 
found that Tara did not bind directly to E-cadherin, but it did 
bind to Trio, which bound to E-cadherin (Fig. 2 A, a). The   
linkage between Trio and E-cadherin was confirmed by binding 
experiments between Trio and a GST fusion protein of the cyto-
plasmic domain of E-cadherin (Fig. 2 A, b), and was consistent 
with the biochemical enrichment of Trio RhoGEF into the junc-
tional fractions and AJ localization of the HA-tagged construct 
of Trio (Fig. 2 A, c; Fig. S2 D).
These results were in accordance with previous reports 
that Trio RhoGEF is associated with cadherin-11 (Kashef et al., 
2009) and M-cadherin (Charrasse et al., 2007) and that Tara 
binds to the RhoG/Rac1-GEF domain (Trio GEF-D1) of Trio 
RhoGEF (Seipel et al., 2001). To address whether Trio plays a 
role in the junctional recruitment of Tara, we knocked down 
Trio in MDCK cells. We observed that the staining for Tara at 
AJs was lost in the Trio knockdown MDCK cells, suggesting 
that the junctional localization of Tara was dependent on the   
E-cadherin/Trio linkage (Fig. S2 E).
In the present study, we used mouse Tara sequence as 
RNAi-resistant sequence and found by immunofluorescence 
and pull-down analyses that the “mid-domain,” between Tara’s 
PH and coiled-coil domains, was responsible for its AJ local-
ization and Trio RhoGEF binding (Fig. 2, B–D). In an immu-
nofluorescence  experiment  using  a  series  of  Tara  deletion 
constructs, all the constructs except the one that lacked the 
mid-domain  increased  the  E-cadherin  expression  levels  in 
Tara-KD cells, indicating that the mid-domain of Tara was re-
quired  to  offset  the  Tara-KD–induced  down-regulation  of   
E-cadherin (Fig. 2, B and C).
Tara-KD decreases E-cadherin expression 
by activating Rac1
To examine Tara-KD’s effect on epithelial cell sheets near con-
fluence, we treated MDCK cells with EDTA/trypsin, replated 
them, and cultured them for 24–48 h to obtain 80–100% conflu-
ency. By immunofluorescence, E-cadherin and Tara were con-
sistently localized to cell–cell AJs at every time point (Fig. S3 A). 
Moreover, when the cells were separated into insoluble and sol-
uble fractions, both E-cadherin and Tara were predominantly 
recovered in the insoluble fraction, supporting the immuno-
fluorescence results (Fig. S3 B). Immunofluorescence and 
immunoblotting showed that the E-cadherin levels were clearly 
lower in the Tara-KD than in the control cells at 24 and 48 h   
after replating (Fig. 3 A; Fig. S3 A). The E-cadherin mRNA was 
also decreased in the Tara-KD cells at 24 and 48 h after replating, 
suggesting that E-cadherin was regulated at the transcription 
level. In contrast, the mRNA level of cadherin-6 did not change 
in the Tara-KD cells (Fig. 3 B). We performed a dual luciferase 
assay using the minimal reporter of E-cadherin and found   
a 40% decrease in reporter expression in the Tara-KD cells JCB • VOLUME 193 • NUMBER 2 • 2011   324
Because the Trio RhoGEF-dependent Rac1 activation was 
specifically up-regulated in Tara-KD cells, we sought to identify 
the signaling cascade that linked the Rac1 activation to the de-
creased E-cadherin expression. In this respect, Rac1 activation 
regulates MAP kinases such as ERK, JNK, and p38 (Rygiel et al., 
2008; Zhang et al., 2009). We therefore examined the phosphory-
lation levels of these MAP kinases by immunoblotting, using anti-
bodies specific for their phosphorylated form. We found that the 
phosphorylation level of p38 was up-regulated in the Tara-KD 
with untreated Tara-KD cells (Fig. 4 E). To complement the 
Trio inhibitor data with an independent maneuver that targets 
Trio, we knocked down Rac1 or Trio in the Tara-KD cells and 
found that the E-cadherin expression was recovered (Fig. S4,   
C and D). These results indicate that the Trio RhoGEF-mediated 
Rac1 activation specifically decreased the E-cadherin expression. 
Together, our findings support the idea that AJ-associated Tara/
Trio RhoGEF spatiotemporally regulates Rac1 activity to alter 
the expression level of E-cadherin.
Figure 3.  Tara-KD–dependent regulation of E-cadherin expression and Rac1 activation. (A) Immunoblotting of control MDCK and Tara-KD cells for E-cadherin, 
cadherin-6, and -catenin at 24 and 48 h after EDTA/trypsin treatment and replating. Note the marked decrease in the protein level of E-cadherin by 
Tara-KD. The protein level of cadherin-6 was increased by Tara-KD compared with control cells. Each of E-cadherin, cadherin-6, Tara, and -catenin was 
probed by its antibody in the presence of the loading control anti–-tub at the same time by mixing antibodies. (B and C) Semi-quantitative RT-PCR (B) and 
luciferase reporter assays (C) for the effect of Tara-KD on E-cadherin mRNA levels and promoter activity, respectively. Note that the E-cadherin mRNA and 
its promoter activity, respectively, decreased significantly at 48 h after cells were seeded (B and C), whereas there was no obvious change in the cadherin-6 
mRNA level (not depicted). The results are expressed as means ± SD (error bars) and are representative of four independent experiments. **, P < 0.01; 
*, P < 0.05. (D) Effect of Tara-KD on the level of active Rac-1 determined by a PAK pull-down assay. The Rac1 activity was increased in Tara-KD cells 24 h 
after replating. The quantification of the immunoblotted signals revealed the significant changes of Rac1 activation by Tara-KD at 24 and 48 h after being 
seeded (see the right panel). ND, not detected. Densitometric quantification of Western blot bands was performed using Photoshop 7.0 (Adobe). As to the 
“Relative Intensity,” the ratio of intensity of GTP-Rac1 to total-Rac in control was normalized to 1.0. The results are expressed as means ± SD (error bars) 
and are representative of three independent experiments. **, P < 0.01; *, P < 0.05. (E) FRET analysis of Rac activation. At 12 and 24 h after replating, 
the Rac1 activation was detected at cell–cell contacts in both control and Tara-KD cells. At 48 h, Rac activation was still detectable in Tara-KD cells but not 
in control cells. Bar, 10 µm.325 Tara regulates transcription of E-cadherin • Yano et al.
Figure 4.  Involvement of Trio in Tara-KD–dependent regulation of E-cadherin expression and Rac1 activation. (A) Schematic drawing of the Tara deletion 
constructs. (B) The Tara domain responsible for regulating the activation of Rac1. The mid-domain of Tara was sufficient to cause the down-regulation of Rac1 
activation in Tara-KD cells. (C) Analysis of the Tara domain responsible for the restoration of E-cadherin in Tara-KD cells, by transfection with Tara deletion mutants. 
Consistent with the Rac1 activity, the mid-domain of Tara was essential to rescue the expression of E-cadherin in Tara-KD cells. (D) Effect of the Trio RhoGEF inhibitor 
ITX3 on the activation level of Rac1 in Tara-KD cells. In the presence of 100 µM ITX3, the Rac1 activation in Tara-KD cells was markedly decreased, to the level in 
control cells. The results are expressed as means ± SD (error bars) and are representative of three independent experiments. **, P < 0.01; *, P < 0.05. Densito-
metric quantification of Western blot bands was performed using Photoshop 7.0 (Adobe). As to the “Relative Intensity,” the ratio of intensities of E-cadherin 
to -tubulin and cadherin-6 to -tubulin in control were normalized to 1.0. (E) Effect of ITX3 on the expression of E-cadherin and cadherin-6 in Tara-KD cells. 
ITX3 blocked the Tara-KD–induced down-regulation of E-cadherin and up-regulation of cadherin-6 in a dose-dependent manner. The right panels show the 
quantification of the immunoblotting data (as shown in Fig. S4 C). The results are expressed as means ± SD (error bars) and are representative of three 
independent experiments, in which antigens were immunoblotted in the same membranes. **, P < 0.01; *, P < 0.05.JCB • VOLUME 193 • NUMBER 2 • 2011   326
the Trio RhoGEF-mediated activation of Rac1 apparently in-
creased the phosphorylation of p38. Consistent with this scenario, 
SB203580, an inhibitor of p38 phosphorylation, suppressed the 
cells compared with controls (Fig. 5 A). When the Trio RhoGEF- 
mediated Rac1 activity was repressed by ITX3 in the Tara-KD 
cells, the phospho-p38 signal decreased (Fig. 5 B). Therefore, 
Figure 5.  Tara-KD regulates the p38MAPK/Tbx3 pathway downstream of Rac1. (A and B) Immunoblotting for phospho-p38MAPK in Tara-KD cells in the 
presence or absence of SB203580 (A) or ITX3 (B). The phosphorylation level of p38MAPK was markedly up-regulated in Tara-KD cells compared with   
control cells. SB203580, a p38MAPK phosphorylation inhibitor, dose dependently decreased the phosphorylation level of p38, as did ITX3, an inhibitor 
of the Rac1-GEF activity of Trio RhoGEF. The bottom panels show the quantification of the immunoblotting data (as shown in Fig. S4 C). The results are   
expressed as means ± SD (error bars) and are representative of three independent experiments. **, P < 0.01; *, P < 0.05. Densitometric quantifica-
tion of Western blot bands was performed using Photoshop 7.0 (Adobe). As to the “Relative Intensity,” the ratio of intensities of P-p38 to p38 in control   
was normalized to 1.0. (C) Immunoblotting for E-cadherin and cadherin-6 in Tara-KD cells. The Tara-KD–induced decrease of E-cadherin and increase of 
cahderin-6 were dose dependently inhibited by the presence of SB203580. The bottom panels show the quantification of the immunoblotting data (Fig. S4 C).   
The basically same results were obtained with another inhibitor of p38, SB202190. The results are expressed as means ± SD (error bars) and are rep-
resentative of three independent experiments, in which antigens were immunoblotted in the same membranes. **, P < 0.01; *, P < 0.05. Densitometric 
quantification of Western blot bands was performed using Photoshop 7.0 (Adobe). As to the “Relative Intensity,” the ratio of intensities of E-cadherin to 
-tubulin and cadherin-6 to -tubulin in control were normalized to 1.0. (D) Immunoblotting of nuclear extracts of Tara-KD and control cells for Tbx3. The 
amount of nuclear Tbx3 in the Tara-KD cells was higher than that in the control cells. SB203850 blocked the increase in nuclear Tbx3 in the Tara-KD cells 
to the control level. (E) The phosphorylation level of nuclear Tbx3 was approximately fourfold increased in the Tara-KD cells compared with control cells, 
and the transfection of HA-Tara or the addition of SB203580 suppressed the increased Tbx3 phosphorylation level by 50%. The results are expressed as 
means ± SD (error bars) and are representative of three independent experiments. **, P < 0.01; *, P < 0.05.327 Tara regulates transcription of E-cadherin • Yano et al.
In the Tara-KD cells, although E-cadherin was decreased, 
the levels of the - and p120-catenins were unchanged. Because 
the - and p120-catenins, respectively, control the ER exit and 
plasma membrane association of classical cadherins (Chen et al., 
1999; Ireton et al., 2002), these findings led us to hypothesize that 
the translation of cadherin-6, another classical cadherin that is 
expressed in MDCK cells, was controlled downstream of the   
E-cadherin transcription. We therefore knocked down E-cadherin 
in MDCK cells, and found that the level of cadherin-6 increased 
(Fig. 6 C). Furthermore, the protein levels of the - and p120-
catenins did not change in the E-cadherin-KD MDCK cells, sug-
gesting there were no changes in the association of the classical 
cadherins with the ER exit or plasma membrane. Hence, if the 
protein expression of one classical cadherin decreases, the other 
cadherins have more p120 available to them, and their levels rise, 
which is referred to as “p120 sharing.” In the present case, the 
cadherin switching was probably driven by the transcriptional 
control of E-cadherin expression. That is, when E-cadherin tran-
scription decreased, the unchanged levels of p120- and -catenins 
drove the concomitant up-regulation of cadherin-6, which does 
not conform to the more canonical EMT-like mechanisms.
Tara-KD affects the organization of the CR
We next investigated the role of the decrease in E-cadherin and 
increase in cadherin-6 at the AJs in MDCK cells. Because AJs 
are highly organized into belt-like arrangement by the periph-
eral actin structure in epithelial cells, which forms the CR, we 
carefully examined the actin intensities at E-cadherin–rich AJs 
in control and Tara-KD MDCK cell sheets by confocal fluores-
cence microscopy (Fig. 7, A–C). To compare the actin intensi-
ties  precisely  between  them,  equal  numbers  of  control  and 
Tara-KD cells were mixed and seeded on a cover glass. Actin stain-
ing with rhodamine-phalloidin was less intense in the Tara-KD 
MDCK cells than in control cells. The actin intensity was re-
stored to normal when exogenous Tara or E-cadherin was ex-
pressed in the Tara-KD MDCK cell sheets (Fig. 7, B and C). 
Furthermore, because the actin CRs form in association with 
the AJs, we examined the CRs stereoscopically by scanning 
electron microscopy (Fig. 7 D). At the AJs of control MDCK 
cell sheets, the actin filaments were closely packed into CRs. In 
contrast, the packing density of the actin filaments in the CRs 
was decreased in the Tara-KD MDCK cells. These findings 
suggested that the E-cadherin–based junctional actin filaments 
of CRs, which cooperate to organize the total AJ, are more 
densely packed at AJs than are the cadherin-6–based ones.
To further explore the biological relevance of Tara we used 
various  morphogenetic  approaches  because  E-cadherin  is 
generally involved in morphogenesis. Among our trials, we ob-
served Tara-KD–dependent morphogenetic phenotypes in three- 
dimensional (3D) cultures of control and Tara-KD MDCK cells 
(Fig. 7 E; Fig. S5). Control MDCK cells formed spherical cysts 
in collagen gels with Y/X ratios (length/width radii) of nearly 1.0 
and Z/X ratios (vertical/horizontal radii) of 0.92 ± 0.07. In contrast, 
the Tara-KD MDCK cells formed 3D cysts that were more ellipti-
cal, with Z/X ratios of 0.62 ± 0.08. Immunofluorescence micros-
copy revealed that, although the intensity of the apical actin 
remained unchanged in the Tara-KD cells, the intensity of actin 
Tara-KD–induced down-regulation of E-cadherin in a dose- 
dependent manner (Fig. 5 C). Quantification by densitometry 
(Fig. 5 C; Fig. S4 B) showed that the E-cadherin signal was 
significantly higher in the SB203580-treated cells (100% 
increase with 10 and 20 µM SB203580). Furthermore, when 
SB202190 was used to inhibit the activity of p38 (Fig. 5 C; 
Fig. S4 E), almost the same results were obtained as those by 
SB203580. Thus, it is likely that Trio RhoGEF-mediated Rac1   
activation increases the phosphorylation of p38, leading to a de-
creased level of E-cadherin in Tara-KD cells.
Tara-KD–based phosphorylation of p38 
phosphorylates Tbx3, a transcriptional 
repressor of E-cadherin that functions 
downstream of Tara/Trio/Rac1/p38
We next investigated how the phosphorylation of p38 decreases 
the expression of E-cadherin. After the EMT-related transcrip-
tion factors had been excluded, the T-box protein family seemed 
the  most  likely  candidates  (Rodriguez  et  al.,  2008). Among 
them, Tbx2 is reported to be phosphorylated by p38 (Abrahams 
et al., 2008), which suggested that Tbx2 could be a downstream 
effector of Tara/Trio/Rac1/p38. However, we did not detect Tbx2 
signals in MDCK cells by immunoblotting, although we did de-
tect Tbx3, which is the most closely related T-box member to 
Tbx2 (Papaioannou and Silver, 1998). Furthermore, the protein 
level of Tbx3 was increased in the nuclei as well as in whole 
Tara-KD cells compared with control cells, and this effect was 
counteracted by SB203580, the p38 phosphorylation inhibitor 
(Fig. 5 D). When we immunoprecipitated Tbx3 from nuclear ex-
tracts and analyzed it using a phosphoprotein detection kit, we 
found  that  its  phosphorylation  was  elevated  in  the  Tara-KD 
cells, but SB203580 reduced this effect (Fig. 5 E). These results 
indicated that Tbx3 is a downstream target of Tara/Trio/Rac1/
p38 and that the phosphorylation and dephosphorylation of Tbx3 
are critical for the transcriptional control of E-cadherin.
The phosphorylation of Tbx3 decreases  
the transcription of E-cadherin  
downstream of Tara/Trio/p38, and  
cadherin-6 is up-regulated
To examine the involvement of Tbx3 phosphorylation in the 
transcriptional control of E-cadherin, we analyzed the effects of 
a dephosphomimetic Tbx3 on the Tara-KD–induced decrease 
in E-cadherin. The likely phosphorylation sites on Tbx3 were 
deduced by comparing its amino acid sequence with that of 
Tbx2 (Fig. 6 A), for which three phosphorylation sites have 
been reported: S336, S623, and S675 (Abrahams et al., 2008).   
There were two corresponding serine residues in Tbx3 (S334 
and S692 with no candidate for S623) that might be phosphory-
lated. Of these, Tbx3 (S692A) had a dominant-negative effect 
on Tbx3’s transcriptional repression of E-cadherin expression 
in Tara-KD cells, and the dephosphomimetic mutation of this 
serine in Tbx3 increased the signals for E-cadherin in the Tara-KD 
cells as shown in immunofluorescence and immunoblotting, re-
spectively (Fig. 6, A and B). These findings led us to conclude 
that Tbx3 is activated by phosphorylation downstream of p38 to 
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signaling cascade is involved in these cases. An important aspect 
of the current findings is that the initiation of an E-cadherin regu-
latory signal at the AJ is conceptually new.
The current work reveals a mechanism by which Rac can 
reduce E-cadherin activity. The source of the Rac activation signal 
is often not clear (Lozano et al., 2008; Hage et al., 2009), and Rac1 
signaling as it pertains to cadherins is still largely unknown. In this 
context, many GEFs are known to be directly or indirectly asso-
ciated with cadherins. In particular, Trio RhoGEF is reported to 
bind M-cadherin and cadherin-11 (Charrasse et al., 2007; Kashef 
et al., 2009), which play distinct roles in development through 
Rac1-related signaling. However, the details of the signaling path-
ways that use RhoG/Rac1 GEF-Trio are still fragmentary.
In the present study, we showed for the first time that the 
Trio RhoGEF-dependent Rac1 signaling that down-regulates   
E-cadherin transcription was dampened by Tara through an inter-
action between the mid-domain of Tara and the RhoG/Rac1-GEF 
domain of Trio. In this respect, Trio bound to the cytoplasmic do-
main of E-cadherin, and Trio knockdown decreased the level of 
Tara at AJs. It is possible that Rac1 activation is at least partly   
mediated  by  Tara-free  E-cadherin–associated  Trio  RhoGEF.   
and E-cadherin at the AJs and lateral membranes of the Tara-KD 
MDCK cell cysts decreased relative to the intensities in control 
cysts. Collectively, these findings indicate that Tara probably plays 
a role in fine-tuning the actin-based tension through the AJs.
Discussion
E-cadherin  is  acknowledged  to  play  critical  roles  in  numer-
ous biological events (Perez-Moreno et al., 2003; Lecuit, 2005;   
Brembeck et al., 2006), which has spurred considerable interest in 
researching E-cadherin–related signaling pathways with a particu-
lar emphasis on their diversity and specificity. Here, we identified 
a novel, specific signaling pathway, Tara/Trio/Rac1/p38/Tbx3/ 
E-cadherin. In this pathway, Tara functions as an AJ component 
and a binding partner of RhoG/Rac1GEF-Trio, which up-regulates 
the transcription of E-cadherin (Fig. 7 F). In this signaling system, 
the Tara-KD–induced down-regulation of E-cadherin transcription 
is independent of EMT in the MDCK cells, which express Tbx3. 
Because the Tbx3-dependent regulation of E-cadherin transcrip-
tion apparently occurs in many important biological events, future 
studies should examine whether the Tara/Trio/Rac1/p38/Tbx3   
Figure  6.  Tbx3-dependent  E-cadherin  ex-
pression  whose  decrease  leads  to  increased   
cadherin-6.  (A  and  B)  Tbx3-dependent   
E-cadherin  expression  in  MDCK  cells  and   
Tara-KD cells. Mouse S692 of Tbx3 (outlined 
in red) was the predicted phosphorylation site,   
based on its conservation with S675 of mouse 
Tbx2. As shown in immunoblotting of stable 
clones  (A)  and  immunofluorescence  micro-
graphs  of  transient  transfectants  (with  green 
nuclei,  B),  when  exogenous  wild-type  Tbx3 
was expressed in MDCK cells, the E-cadherin 
expression was decreased, and the cadherin-6   
expression  increased  concomitantly.  The  de-
phosphomimic Tbx3 (Tbx3-S692A) showed no 
inhibition of E-cadherin expression (A). When 
exogenous wild-type Tbx3 was expressed in 
MDCK  cells,  the  E-cadherin  expression  was 
decreased, and the cadherin-6 expression in-
creased  concomitantly.  The  dephosphomimic 
Tbx3 (Tbx3-S692A) showed no inhibition of 
E-cadherin  expression.  The  dephosphomi-
metic Tbx3 suppressed the down-regulation of   
E-cadherin and the up-regulation of cadherin-6   
in  Tara-KD  cells.  Densitometric  quantification 
of Western blot bands was performed using 
Photoshop  7.0  (Adobe).  As  to  the  “Relative 
Intensity,” the ratio of intensities of E-cadherin 
to -tubulin and cadherin-6 to -tubulin in con-
trol were normalized to 1.0. The results are 
expressed as means ± SD (error bars) and are 
representative of three independent experiments, 
in  which  antigens  were  immunoblotted  in  the 
same membranes. **, P < 0.01; *, P < 0.05. 
The transfected cells are the ones with green 
nuclei. Bar, 10 µm. (C) Knockdown of E-cadherin 
in  MDCK  cells.  E-cadherin,  red;  cadherin-6, 
green (cy5-staining). Bar, 10 µm. When the 
immunofluorescent signals of E-cadherin were 
decreased  by E-cadherin-KD  in  MDCK  cells, 
those for cadherin-6 increased.329 Tara regulates transcription of E-cadherin • Yano et al.
phosphatase  domain  in  its  cytoplasmic  region  that  binds   
-  and  -catenin.  This  finding  suggests  that  LAR-related   
signals may modulate the link between Tara and Trio RhoGEF,   
to  activate  its  Rac1-GEF  activity.  It  is  also  possible  that   
cell–cell adhesion-based signals modulate the link between 
Trio RhoGEF and E-cadherin, which will be a subject of fu-
ture study.
Tara functions to maintain E-cadherin transcription by spatio-
temporally inhibiting Rac activation in cell–cell adhesion-based 
events through the Tara/Trio RhoGEF/Rac1/p38/Tbx3 signaling 
cascade. The relationship of Rac1 to E-cadherin activity has been 
poorly understood, and this work adds new insight to the story.
Interestingly, Trio RhoGEF is reportedly anchored to 
LAR (Debant et al., 1996), a transmembrane protein with a 
Figure 7.  Tara-dependent maturation of the 
circumferential ring. (A–C) Confocal immuno-
fluorescence micrographs of Tara-KD cells with 
or  without  transfection  of  HA-Tara  or  YFP– 
E-cadherin cultured with untransfected control 
MDCK cells. In co-cultures of control and Tara-
KD cells, the Tara-KD cells showed a lower ac-
tin signal intensity at the zAJ/CR and cell–cell 
contacts than the control cells (A). In contrast, 
Tara-KD cells transfected with HA-Tara (B) or 
YFP-E-cadherin (C) exhibited actin signal inten-
sities similar to the control cells. Bar, 10 µm.   
(A and B) HA, green; actin, red. (C) YFP, green; 
actin, red. (D) Scanning electron micrographs 
of Tara-KD cells with or without transfected HA-
Tara or YFP–E-cadherin. The actin filaments of 
the CR were more loosely packed in the Tara-
KD cells compared with the control cells. HA-
Tara or YFP–E-cadherin partially restored the 
packing density of the CR actin filaments. Bar, 
5 µm. (E) Electron micrographs of 3D cultures 
(cysts) of control cells and Tara-KD cells with 
or  without  transfection  of  HA-Tara  or  YFP– 
E-cadherin. Thin-section electron micrographs 
revealed  that  the  spherical  cell  cysts  were 
composed of a single-layered sheet of epithe-
lial cells. Bar, 2 µm. The vertical-to-horizontal 
(Z/X) ratio of the diameters of control cell cysts 
was  0.92  (n  =  10).  The  Tara-KD  cell  cysts 
were elliptical, and Tara-KD cells expressing 
exogenous HA-Tara or YFP–E-cadherin formed 
spherical cell cysts similar to the control cells. 
The Z/X ratios of the cell cysts made by Tara-
KD cells, Tara-KD cells expressing HA-Tara, or 
Tara-KD cells expressing YFP–E-cadherin were   
0.62, 0.87, and 0.91, respectively (n = 10). 
(F) Schematic drawing of the novel Tara/Trio   
RhoGEF/Rac1/p38MAPK/Tbx3/E-cadherin   
signaling cascade proposed here. This Tara/ 
Trio/Rac1/p38/Tbx3 signaling cascade is the 
first E-cadherin–based AJ-initiated signal reported 
to  regulate  the  transcription  of  E-cadherin  in 
epithelial cell sheets. Here we found that Tara 
is enriched at AJs through its association with 
Trio RhoGEF, a binding partner of E-cadherin.   
By negatively regulating the RhoGEF activity   
of Trio in an EMT-independent manner, Tara 
down-regulates  the  activity  of  Tbx3,  a  tran-
scriptional  suppressor  of  E-cadherin.  Further-
more, we found that Tara-KD remodeled the 
actin CR by decreasing the level of E-cadherin   
expression,  although  the  protein  level  of 
cadherin-6 increased. We propose that Tara 
is a critical regulator of E-cadherin expression, 
and through this regulation Tara fine-tunes the 
cadherin-based actin CR and other properties 
of epithelial cell sheets.JCB • VOLUME 193 • NUMBER 2 • 2011   330
research directions on the roles of E-cadherin–related signaling 
cascades. Further analyses of this cascade in vivo and of other 
signals that regulate E-cadherin transcription should elucidate 
ways to manipulate development-, regeneration-, and/or tumor-
related processes for novel strategies in medical therapies. Studies 
along these lines are being conducted in our laboratory.
Materials and methods
Antibodies and reagents
To generate an anti-Tara pAb, rabbits were immunized with a GST-Tara 
(111–190 aa) fusion protein. Mouse anti–cadherin-6 pAb was a special 
gift from Dr. M. Takeichi (Center for Developmental Biology, Kobe, Japan) 
and  was  generated  using  cadherin-6  knockout  mice.  Rat  anti-occludin 
(MOC37) and anti-ZO1 mAbs were generated and characterized in our 
laboratory (Saitou et al., 1998; Kitajiri et al., 2004). Rat anti–E-cadherin 
mAb  was  kindly  provided  by  Dr.  M.  Takeichi.  Mouse  anti-HA  mAb   
(Covance),  goat  anti–ZO-2  pAb,  rabbit  anti-Trio  pAb,  rabbit  anti-Tbx3 
pAb, anti–lamin B pAb (Santa Cruz Biotechnology, Inc.), anti-p38, anti–
phospho  p38  (Cell  Signaling  Technology),  rabbit  anti–claudin-3  pAb   
(Invitrogen),  mouse  anti-Rac1  mAb  (Millipore),  mouse  anti-desmoplakin 
mAb (Progen), mouse anti-Trio pAb (Abnova), and mouse and rabbit anti-
Tbx3 pAbs (Abcam) were purchased. Rabbit anti–-catenin pAb, rabbit anti– 
-catenin pAb, mouse anti-vinculin mAb, mouse anti-Flag mAb, and mouse 
anti–-tubulin mAb were from Sigma-Aldrich. SB203580 was from EMD. 
ITX3 was described previously (Bouquier et al., 2009). The Phosphoprotein   
Colorimetric Assay kit, Pro-Q, was from Invitrogen.
Plasmids and primers
The cDNA clones encoding Tara and Tbx3 were isolated from a mouse 
liver and kidney cDNA library. The Tara cDNA was cloned into the 
pCAGGS-NHA vector, and Tbx3 and its mutant were cloned into the pAcGFP-
C1 vector (Takara Bio Inc.). The pGEX4T1-CRIB-Pak used for the pull-down 
assays of Rac1 was described previously (Matsuo et al., 2002; Ikenouchi 
et al., 2007). The primers for E-cadherin and GAPDH used for quantitative 
RT-PCR and the E-cadherin promoter used for luciferase assays were de-
scribed previously (Behrens et al., 1991; Youn et al., 2005).
Knockdown constructs
To suppress the expression of Tara in MDCK cells, DNA oligonucleotides of 
target sequences encoding two distinct portions of the respective ORFs 
were cloned into an H1 promoter-driven RNAi vector (Brummelkamp et al., 
2002). The vectors were transfected into MDCK cells, and suppressed the 
expression of Tara. Four clones obtained from the two constructs were se-
lected.  The  probe  sequences  were:  Tara  (112–130),  5-GGAGAGTG-
GAAGAAGCATT-3;  Tara  (117–135),  5-GTGGAAAGAAGCATTGGTTT-3; 
Tara  Scramble,  5-TTACGAAGAAGGTGAGAGG-3;  Trio  (305–323),   
5-GCATTCATGTTGCACTGAT-3;  Rac1  (552–570),  5-GAGGAAGAGA-
AAATGCCTG-3. The probe sequences for E-cadherin and cadherin-6 were 
reported previously (Capaldo and Macara, 2007).
Cell culture and transfections
MDCK-II and HEK293 cells were grown in DME supplemented with 10% 
fetal calf serum. Transfection was performed using the Lipofectamine Plus 
Reagent (Invitrogen), according to the manufacturer’s instructions. Most   
results shown were from transfected MDCK-II cells.
Immunofluorescence microscopy
MDCK cells were fixed in 1% formalin for 5 min at room temperature. The 
cells were then treated with 0.2% Triton X-100 in PBS for 5 min and pro-
cessed  for  immunofluorescence  microscopy  as  described  previously 
(Yamazaki et al., 2008b). Alexa Fluor 488– or 568–conjugated second-
ary antibodies were used. For actin staining, Alexa Fluor 568 phalloidin 
(Invitrogen) was added to the secondary antibody. Specimens were ob-
served at RT with a photomicroscope (BX51 and BX70; Olympus) equipped 
with a 100x, 1.4 NA oil immersion lens; 60x, 1.42 NA oil immersion lens; 
and 20x, 0.5 NA lens, and with a confocal microscope (Axiovert 200M; 
Carl Zeiss, Inc.) equipped with a Plan-Apochromat (63x/1.40 NA oil im-
mersion objective) with appropriate binning of pixels and exposure time. 
Photographs were recorded with a cooled CCD camera (ORCA-ER, Hama-
matsu Photonics; or CoolSnap HQ, Photometrics). The images were ana-
lyzed  with  IPLab  version  3.9.5  (BD),  MetaMorph  (Molecular  Devices), 
LSM510  Meta  version  3.0  (Carl  Zeiss,  Inc.),  and  Deltavision  software   
Although the general idea that Rac1 activation alters the 
localization and/or the total protein level of E-cadherin in cells 
is being established (Lozano et al., 2008; Hage et al., 2009), this 
is the first example of Rac1 regulating the transcription of   
E-cadherin, as indicated by our finding that Trio RhoGEF-based 
Rac1 activity up-regulates the phosphorylation level of p38 in-
dependent of EMT, to down-regulate E-cadherin transcription. 
This function of the Rac1/p38 pathway may have conceptual 
implications for understanding Rac1/p38 pathways in general 
because only a few cases involve a signaling route from p38 to 
cadherins, and in these cases, the phosphorylation of p38 was 
reported to affect the post-transcriptional down-regulation of 
cadherins (Zohn et al., 2006; Khanna et al., 2010). Recently, 
p38  was  reported  to  phosphorylate  Tbx2  (Abrahams  et  al., 
2008), and Tbx2/3 were reported to down-regulate the tran-
scription of E-cadherin (Rodriguez et al., 2008). However, these 
distinct events have not been linked, as they have been in this 
study, where we show that Rac1/p38 directly regulates the tran-
scription of E-cadherin.
Despite the decreased expression of E-cadherin caused by 
the Tara knockdown, the Tara-KD cells did not induce an EMT, 
and retained their configuration as an epithelial cell sheet, pre-
sumably because of the concomitant up-regulation of cadherin-6. 
These findings were reminiscent of “cadherin switching,” the 
phenomenon in which two or more cadherins show a seesaw 
pattern of protein expression, although cadherin switching   
under non-EMT circumstances is relatively undocumented 
(Wheelock et al., 2008). In this respect, transfection of Snail did 
not show any influence on the expression of Tara (Ikenouchi   
et al., 2003; unpublished data). Our present data show a detailed 
example of molecular signaling mechanisms leading to cad-
herin switching in a non-EMT situation.
A final issue relates to the cadherin-based junctional CR. 
Classical  cadherins,  with  which  -catenin  is  associated,  are 
linked to the CR through -catenin/eplin/actin (Abe and Takeichi, 
2008). Our present findings suggest that each type of classical 
cadherin has a distinct CR-organizing activity. These findings 
provide a new perspective on the higher-order structures of AJs. 
Because the AJ-based CR was first observed in various types of 
epithelia in vivo, CRs of epithelial cell sheets have been thought 
to contain E-cadherin and/or classical cadherins in a ring-like   
arrangement (Mooseker, 1976; Owaribe et al., 1981). The den-
sity of the actin belt in CRs varies with the cell/tissue type, but 
the mechanism for regulating actin packing in CRs is not well 
understood. We propose here that the density of the actin belt in 
CRs might be determined by the balance between the classical 
cadherins expressed in the AJs of a given cell type. If this is the 
case, Tara  might  contribute  to  the  morphogenesis  of  various 
parts of the body by spatiotemporally modulating the balance of 
the classical cadherins.
In conclusion, we found that Tara/Trio RhoGEF/Rac1/p38/
Tbx3 is a novel signaling cascade involved in the remodeling   
of  epithelial  cell  sheets  by  regulating  the  transcription  of   
E-cadherin. These findings reveal for the first time that the   
AJ-associated E-cadherin complex regulates the transcription of 
E-cadherin. These discoveries will be critical to fully understand 
E-cadherin’s diverse and specific functions, and to suggest new 331 Tara regulates transcription of E-cadherin • Yano et al.
additional characterization of the mechanism of Tara-KD–induced down-
regulation of E-cadherin. Fig. S4 shows additional analysis of Tara-KD– 
mediated  signals.  Fig.  S5  shows  characterization  of  cyst  formation  of 
Tara-KD cells. Video 1 shows FRET analysis for Raichu-Rac1 in the mock 
control cells between 11 and 13 h after being seeded. Video 2 shows FRET 
analysis for Raichu-Rac1 in the mock control cells between 23 and 25 h   
after being seeded. Video 3 shows FRET analysis for Raichu-Rac1 in the 
mock control cells between 47 and 49 h after being seeded. Video 4 
shows FRET analysis for Raichu-Rac1 in the Tara-KD cells between 11 and 
13 h after being seeded. Video 5 shows FRET analysis for Raichu-Rac1 in 
the mock control cells between 23 and 25 h after being seeded. Video 6 
shows FRET analysis for Raichu-Rac1 in the mock control cells between 47 
and 49 h after being seeded. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201009100/DC1.
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GST pull-down and immunoprecipitation
HEK293 cells were transfected with expression vectors. The lysates from 
these cells were mixed with GST 4b beads (GE Healthcare) preabsorbed 
with GST fusion proteins. The nuclei were isolated from MDCK cells as re-
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Rac1 activity assay
GTP-loaded  Rac1  was  measured  using  a  commercially  available  kit 
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Immunoblotting
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FRET analyses
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University, Kyoto, Japan). Raichu probes were transiently transfected into 
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In the IMD mode images (Ratio), eight colors from red to blue are 
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3D culture in collagen gel
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Scanning and transmission electron microscopy
Cells were cultured in Transwell inserts or collagen gels. For scanning elec-
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Statistical analysis
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cific types of tests and the P values, when applicable, are indicated in the 
figure legends.
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